Laboratory J. Andrew Pospisilik
Epigenetic control of complex disease
Current estimates place the prevalence of diabetes and obesity in the range of 300 million to beyond 1 billion by the year 2030. As critical risk factors for heart disease, cancer and stroke, obesity and diabetes currently represent one of the world's chief economic and health care challenges. While studies have established elegant genetic frameworks for our current understanding of these complex disorders, the contribution of a number of critical regulatory layers, in particular epigenetic regulation, remain poorly understood.
Our lab is interested in defining epigenetic regulatory systems that contribute to the susceptibility and development of complex disease. These paradigms are broad and include, among others, post-translational modifications of histones, non-coding RNAs, and modifiers of chromatin stability such as the Polycomb-Trithorax Groups. What is clear at present is that these epigenetic effectors play a critical role in defining set-points for entire functional gene sets; the fundamental outstanding question we are interested in is how these epigenetic cues influence the susceptibility and development of human disease.
Group Leader
1976
Born in Vancouver, Canada
Undergraduate studies in Physiology at the University of British Columbia, Vancouver, Canada
2003
PhD studies at the University of British Columbia, Vanvouver, Canada
2004-2009
Postdoctoral fellow at the Institute of Molecular Biotechnology, Vienna, Austria
Since March 2010
Group Leader at the Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Project Areas
-
Epigenetic Control of Complex Disease
Chromatin plasticity in metabolism and cancer. Introduction. Current estimates place the prevalence of diabetes and obesity in the range of 300 million to...
more details >
-
Functional translation of epigenetic cues
A compliment to the first strategy, our second long-term goal is to functionally characterize disease-specific epigenetic modifications in vivo. These studies,...
more details >
Recent Publications
-
Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.
Teperino, R., Amann, S., Bayer, M., McGee, S.L., Loipetzberger, A., Connor, T., Jaeger, C., Kammerer, B., Winter, L., Wiche, G., Dalgaard, K., Selvaraj, M., Gaster, M., Young, R.L., Febbraio, M.A., Knauf, C., Cani, P.D., Aberger, F., Penninger, J.M., Pospisilik, J.A.*, Esterbauer, H.E.* (2012)
Cell 151, 414-426
-
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism.
Haschemi, A., Kosma, P., Gille, L., Evans, C.R., Burant, C.F., Starkl, P., Knapp, B., Haas, R., Schmid, J.A., Jandl, C., Amir, S., Lubec, G., Park, J., Esterbauer, H., Bilban, M., Brizuela, L., Pospisilik, J.A., Otterbein, L.E., Wagner, O. (2012)
Cell Metab 15, 813-826
-
Variants in STAT5B associate with serum TC and LDL-C levels.
Kornfeld, J.W., Isaacs, A., Vitart, V., Pospisilik, J.A., Meitinger, T., Gyllensten, U., Wilson, J.F., Rudan, I., Campbell, H., Penninger, J.M., Sexl, V., Moriggl, R., van Duijn, C., Pramstaller, P.P., Hicks, A.A. (2011)
J Clin Endocrinol Metab. 96, 1496-1501
-
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
Mueller, K.M., Kornfeld, J.W., Friedbichler, K., Blaas, L., Egger, G., Esterbauer, H., Hasselblatt, P., Schlederer, M., Haindl, S., Wagner, K.U., Engblom, D., Haemmerle, G., Kratky, D., Sexl, V., Kenner, L., Kozlov, A.V., Terracciano, L., Zechner, R., Schuetz, G., Casanova, E., Pospisilik, J.A., Heim, M.H., Moriggl, R. (2011)
Hepatology 54, 1398-1409
-
Cross-talk between interferon-y and hedgehog signaling regulates adipogenesis.
Todoric, J., Strobl, B., Jais, A., Boucheron, N., Bayer, M., Amann, S., Lindroos, J., Teperino, R., Prager, G., Bilban, M., Ellmeier, W., Krempler, F., Müller, M., Wagner, O., Patsch, W., Pospisilik, J.A.*, Esterbauer, H.* (2011)
Diabetes 60, 1668-1676
-
Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice.
Duparc, T., Colom, A., Cani, P.D., Massaly, N., Rastrelli, S., Drougard, A., Le Gonidec, S., Moulédous, L., Frances, B., Leclercq, I., Llorens-Cortes, C., Pospisilik, J.A., Delzenne, N.M., Valet, P., Castan-Laurell, I., Knauf, C. (2011)
Antioxid Redox Signal 16, 1477-1496
-
The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression.
Schramek, D., Kotsinas, A., Meixner, A., Wada, T., Elling, U., Pospisilik, J.A., Neely, G.G., Zwick, R.H., Sigl, V., Forni, G., Serrano, M., Gorgoulis, V.G., Penninger, J.M. (2011)
Nat Genet. 43, 212-219
-
A genome-wide Drosophila screen for heat nociception identifies ?2?3 as an evolutionarily conserved pain gene.
Neely, G.G., Hess, A., Costigan, M., Keene, A.C., Goulas, S., Langeslag, M., Griffin, R.S., Belfer, I., Dai, F., Smith, S.B., Diatchenko, L., Gupta, V., Xia, C.P., Amann, S., Kreitz, S., Heindl-Erdmann, C., Wolz, S., Ly, C.V., Arora, S., Sarangi, R., Dan, D., Novatchkova, M., Rosenzweig, M., Gibson, D.G., Truong, D., Schramek, D., Zoranovic, T., Cronin, S.J., Angjeli, B., Brune, K., Dietzl, G., Maixner, W., Meixner, A., Thomas, W., Pospisilik, J.A., Alenius, M., Kress, M., Subramaniam, S., Garrity, P.A., Bellen, H.J., Woolf, C.J., Penninger, J.M. (2010)
Cell 143, 628-38
-
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.
Schramek, D., Leibbrandt, A., Sigl, V., Kenner, L., Pospisilik, J.A., Lee, H.J., Hanada, R., Joshi, P.A., Aliprantis, A., Glimcher, L., Pasparakis, M., Khokha, R., Ormandy, C.J., Widschwendter, M., Schett, G., Penninger, J.M. (2010)
Nature 468, 98-102
-
Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet.
Ehses, J.A., Meier, D.T., Wueest, S., Rytka, J., Boller, S., Wielinga, P.Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., Pospisilik, J.A., Tschopp, O., Schultze, S.M., Malipiero, U., Esterbauer, H., Ellingsgaard, H., Rütti, S., Schuit, F.C., Lutz, T.A., Böni-Schnetzler, M., Konrad, D. and Donath, M.Y. (2010)
Diabetologia Epub Apr21
-
A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function.
Neely, G.G., Kuba, K., Cammarato, A., Isobe, K., Amann, S., Zhang, L., Murata, M., Elmén, L., Gupta, V., Arora, S., Sarangi, R., Dan, D., Fujisawa, S., Usami, T., Xia, C.P., Keene, A.C., Alayari, N.N., Yamakawa, H., Elling, U., Berger, C., Novatchkova, M., Koglgruber, R., Fukuda, K., Nishina, H., Isobe, M., Pospisilik, J.A., Imai, Y., Pfeufer, A., Hicks, A.A., Pramstaller, P.P., Subramaniam, S., Kimura, A., Ocorr, K., Bodmer, R. and Penninger, J.M. (2010)
Cell 141, 142-53
-
Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate.
Pospisilik, J.A., Schramek, D., Schnidar, H., Cronin, S.J., Nehme, N.T., Zhang, X., Knauf, C., Cani, P.D., Aumayr, K., Todoric, J., Bayer, M., Haschemi, A., Puviindran, V., Tar, K., Orthofer, M., Neely, G.G., Dietzl, G., Manoukian, A., Funovics, M., Prager, G., Wagner, O., Ferrandon, D., Aberger, F., Hui, C.C., Esterbauer, H. and Penninger, J.M. (2010)
Cell 140, 148-60
Group Members
-
Group Leader
Pospisilik, John Andrew
phone: -757
-
Postdoctoral Fellows
Gossens, Klaus
phone: -792
-
Jayaramaiah Raja, Sunil
phone: -793
-
Lempradl, Adelheid
phone: -757
-
Öst, Anita
phone: -793
-
Teperino, Raffaele
phone: -793
-
Ph.D. Students
Dalgaard, Kevin
phone: -792
-
Longinotto, John
phone: -793
-
Lu, Tsai-Hsiu
phone: -792
-
Selvaraj, Madhan
phone: -793
-
Technicians
Ruf, Marius
phone: -792
-
Student Assistants
Tran, Quyen
phone: -792
print this page